Systemic immune-inflammation index (SII) and the risk of all-cause, cardiovascular, and cardio-cerebrovascular mortality in the general population

[1] Townsend N(2016)Cardiovascular disease in Europe: epidemiological update 2016 Eur Heart J 37 3232-3245

[2] Wilson L(2018)Heart disease and stroke Statistics-2018 update: a report from the American Heart Association Circulation 137 e67-e492

[3] Bhatnagar P(2011)Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 933-944

[4] Wickramasinghe K(2021)Differences in the prevention and control of cardiovascular and cerebrovascular diseases Pharmacol Res 170 1736-1788

[5] Rayner M(2018)Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017 Lancet 392 535-546

[6] Nichols M(2016)Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease Circ Res 118 107-120

[7] Benjamin EJ(2019)Immunity and inflammation in atherosclerosis Herz 44 524-533

[8] Virani SS(2021)The changing landscape of atherosclerosis Nature 592 851-860

[9] Callaway CW(2016)The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease Ther Clin Risk Manag 27 363-371

[10] Chamberlain AM(2019)Atherosclerosis and immunity: a perspective Trends Cardiovasc Med 29 2045-2051

[1] Townsend N(2016)Cardiovascular disease in Europe: epidemiological update 2016 Eur Heart J 37 3232-3245

[2] Wilson L(2018)Heart disease and stroke Statistics-2018 update: a report from the American Heart Association Circulation 137 e67-e492

[3] Bhatnagar P(2011)Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 933-944

[4] Wickramasinghe K(2021)Differences in the prevention and control of cardiovascular and cerebrovascular diseases Pharmacol Res 170 1736-1788

[5] Rayner M(2018)Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017 Lancet 392 535-546

[6] Nichols M(2016)Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease Circ Res 118 107-120

[7] Benjamin EJ(2019)Immunity and inflammation in atherosclerosis Herz 44 524-533

[8] Virani SS(2021)The changing landscape of atherosclerosis Nature 592 851-860

[9] Callaway CW(2016)The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease Ther Clin Risk Manag 27 363-371

[10] Chamberlain AM(2019)Atherosclerosis and immunity: a perspective Trends Cardiovasc Med 29 2045-2051